Clavien grade II complications | Clavien grade ≥ III (severe) complications | |||
---|---|---|---|---|
Type of complication | Landiolol (n = 28) | Placebo (n = 28) | Landiolol (n = 28) | Placebo (n = 28) |
All | 4 (14.2) | 7 (25.0) | 7 (25.0) | 7 (25.0) |
Mortality | 0 (0.0) | 0 (0.0) | 1 (3.6) | 0 (0.0) |
Gastric tube necrosis | 1 (3.6) | 0 (0.0) | 2 (7.1) | 0 (0.0) |
Anastomotic stenosis | 0 (0.0) | 0 (0.0) | 1 (3.6) | 0 (0.0) |
Anastomotic leakage | 1 (3.6) | 0 (0.0) | 5 (17.9) | 3 (10.7) |
Pneumonia | 0 (0.0) | 3 (10.7) | 0 (0.0) | 0 (0.0) |
Vocal cord paralysis | 2 (7.1) | 3 (10.7) | 0 (0.0) | 0 (0.0) |
Supraventricular tachycardia | 0 (0.0) | 1 (3.6) | 0 (0.0) | 0 (0.0) |
Sepsis | 0 (0.0) | 1 (3.6) | 0 (0.0) | 0 (0.0) |
Pleural effusion | 0 (0.0) | 1 (3.6) | 0 (0.0) | 4 (14.3) |
Intestinal ischemia | 0 (0.0) | 0 (0.0) | 1 (3.6) | 0 (0.0) |
Intrathoracic bleeding | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (3.6) |